• About
• Links
• Contact
• Sitemap
• 

The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates Challenges

Summary

The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis.

Scope

The scope of this report includes:

Annualized market data for the pain management market from 2001 to 2009, forecast forward to 2016.

Analysis of the leading therapeutic segments, including neuropathic pain, osteoarthritis, cancer pain, migraine and fibromyalgia.

Analysis of the pain management market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.

Market characterization of the pain management market including market size, the annual cost of therapy, sales volume and treatment usage patterns.

Key drivers and barriers that have a significant impact on the market.

Coverage of pipeline molecules in the various phases of drug development.

Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer, Inc., Eli Lilly and Company, Johnson & Johnson, Novartis AG, Merck & Co Inc., and Cephalon, Inc.

Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global pain management market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to

Align product portfolio to the markets with high growth potential

Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth

Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety

Develop key strategic initiatives by understanding key focus areas of leading companies

Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Table of Contents

1 Table of Contents 4

• 1.1 List of Tables 7
• 1.2 List of Figures 10

2 Global Pain Management Therapeutics Market: Introduction 13

• 2.1 Research Report Guidance 13

3 Global Pain Management Therapeutics Market: Market Overview 14

• 3.1 Introduction 14
• 3.2 Revenue Forecast for the Global Pain Management Therapeutics Market 15
  • 3.2.1 Sales Value 15
  • 3.2.2 Patient Volume 16
  • 3.2.3 Annual Cost of Therapy 17
  • 3.2.4 Treatment Usage Patterns 18
  • 3.2.5 Generics’ Share in the Global Pain Management Therapeutics Market 23
  • 3.2.6 Sales of Leading Drugs 24
• 3.3 Pain Management Therapeutics Market Drivers 25
  • 3.3.1 Increase in Diagnosed and Prescription Population 25

4 Global Pain Management Therapeutics Market: Therapeutic Landscape 26

• 4.1 Fibromyalgia Market 26
  • 4.1.1 Introduction 26
  • 4.1.2 Sales Value 26
  • 4.1.3 Patient Volume 28
  • 4.1.4 Annual Cost of Therapy 29
  • 4.1.5 Treatment Usage Patterns 30
  • 4.1.6 Drivers for Fibromyalgia Pain Market 35
  • 4.1.7 Restraints for Fibromyalgia Pain Market 36
  • 4.1.8 Unmet Needs 36
• 4.2 Neuropathic Pain Market 36
  • 4.2.1 Introduction 36
  • 4.2.2 Sales Value 37
  • 4.2.3 Patient Volume 38
  • 4.2.4 Annual Cost of Therapy 39
  • 4.2.5 Treatment Usage Patterns 40
  • 4.2.6 Drivers for Neuropathic Pain Market 45
  • 4.2.7 Restraints for Neuropathic Pain Market 46
  • 4.2.8 Unmet Need 46
• 4.3 Migraine Market 46
  • 4.3.1 Introduction 46
  • 4.3.2 Sales Value 47
  • 4.3.3 Patient Volume 48
  • 4.3.4 Annual Cost of Therapy 49
  • 4.3.5 Treatment Usage Patterns 50
  • 4.3.6 Drivers for Migraine Market 55
  • 4.3.7 Restraints for Migraine Market 55
  • 4.3.8 Unmet Need 56
• 4.4 Cancer Pain Market 56
  • 4.4.1 Introduction 56
  • 4.4.2 Sales Value 56
  • 4.4.3 Patient Volume 58
  • 4.4.4 Annual Cost of Therapy 59
  • 4.4.5 Treatment Usage Patterns 60
  • 4.4.6 Drivers for Cancer Pain Market 64
  • 4.4.7 Restraints for Cancer Pain Market 65
  • 4.4.8 Unmet Need 65
• 4.5 Osteoarthritis Pain Market 65
  • 4.5.1 Introduction 65
  • 4.5.2 Sales Value 66
  • 4.5.3 Patient Volume 67
  • 4.5.4 Annual Cost of Therapy 68
  • 4.5.5 Treatment Usage Patterns 69
  • 4.5.6 Drivers for Osteoarthritis Pain Market 73
  • 4.5.7 Restraints for Osteoarthritis Pain Market 74
  • 4.5.8 Unmet Need 74

5 Global Pain Management Therapeutics Market: Geographical Landscape 75

• 5.1 Geographical Break-up 75
• 5.2 The US 77
  • 5.2.1 Sales Value 77
  • 5.2.2 Patient Volume 78
  • 5.2.3 Annual Cost of Therapy 79
  • 5.2.4 Treatment Usage Patterns 80
• 5.3 Top Five Countries in Europe 85
  • 5.3.1 Sales Value 85
  • 5.3.2 Patient Volume 86
  • 5.3.3 Annual Cost of Therapy 87
  • 5.3.4 Treatment Usage Patterns 88
• 5.4 Japan 93
  • 5.4.1 Sales Value 93
  • 5.4.2 Patient Volume 94
  • 5.4.3 Annual Cost of Therapy 95
  • 5.4.4 Treatment Usage Patterns 96

6 Global Pain Management Therapeutics Market: Pipeline Analysis 102

• 6.1 Introduction 102
  • 6.1.1 Research and Development Pipeline – Fibromyalgia 103
  • 6.1.2 Research and Development Pipeline – Neuropathic Pain 104
  • 6.1.3 Research and Development Pipeline – Migraine 105
  • 6.1.4 Research and Development Pipeline – Cancer Pain 106
  • 6.1.5 Research and Development Pipeline – Osteoarthritis Pain 106
• 6.2 Profiles of Key Late-Stage Drugs in the Pain Management Market 107
  • 6.2.1 Droxopida 107
  • 6.2.2 Xyrem 107
  • 6.2.3 Vimpat (lacosamide) 107
  • 6.2.4 Qutenza (capsaicin 8%) 108
  • 6.2.5 Botox 109
  • 6.2.6 Tezampanel 110
  • 6.2.7 Nasalfent 110
  • 6.2.8 PF-4383119 (Tanezumab) 111

7 Global Pain Management Therapeutics Market: Competitive Landscape 112

• 7.1 Market Share Analysis 112
• 7.2 Competitive Profiling 112
  • 7.2.1 Pfizer, Inc. 114
  • 7.2.2 Eli Lilly and Company 115
  • 7.2.3 Johnson & Johnson 117
  • 7.2.4 Endo Pharmaceuticals 119
  • 7.2.5 Novartis AG 120
  • 7.2.6 Merck & Co Inc 122
  • 7.2.7 Cephalon, Inc. 123

8 Global Pain Management Therapeutics Market: Strategic Consolidations 125

• 8.1 Overview 125
  • 8.1.1 Sanofi-Aventis Acquired 100% outstanding shares of Chattem, Inc in December 2009 127
  • 8.1.2 Dainippon Sumitomo Pharma Acquired Sepracor, Inc. in October 2009 127
  • 8.1.3 Raptor Pharmaceuticals and TorreyPines Therapeutics Merged in August 2009 127
  • 8.1.4 Alexza Pharmaceuticals Acquired Symphony Allegro in June 2009 127
  • 8.1.5 Anesiva and Arcion Therapeutics Merge in May 2009 127
  • 8.1.6 Mylan Laboratories Acquired Matrix Laboratories Limited in March 2009 128
• 8.2 R&D Licensing Agreements 128
  • 8.2.1 Deals by Indication 128
  • 8.2.2 Deals by Phase 129
  • 8.2.3 Deals by Geography 130
  • 8.2.4 Deals by Value ($) 131
  • 8.2.5 Preclinical and Discovery 131
  • 8.2.6 Phase I 132
  • 8.2.7 Phase II 132
  • 8.2.8 Phase III 133
  • 8.2.9 Approved and Regulatory Filing 134

9 Global Pain Management Therapeutics Market: Appendix 136

• 9.1 Market Definitions 136
• 9.2 Abbreviations 136
• 9.3 Research Methodology 137
  • 9.3.1 Coverage 137
  • 9.3.2 Secondary Research 138
  • 9.3.3 Primary Research 138
  • 9.3.4 Forecasts 138
  • 9.3.5 Expert Panel Validation 140
• 9.4 Contact Us 141
• 9.5 Disclaimer 141
• 9.6 Sources 141

1.1 List of Tables

• Table 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2009 16
• Table 2: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2009-2016 16
• Table 3: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2001-2009 17
• Table 4: Pain Management Therapeutics Market, Global, Patient Volume (Millions), 2009-2016 17
• Table 5: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2001-2009 18
• Table 6: Pain Management Therapeutics Market, Global, Annual Average Cost of Therapy ($), 2009-2016 18
• Table 7: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2001-2009 19
• Table 8: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2009-2016 20
• Table 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 24
• Table 10: Pain Management Therapeutics Market, Global, Sales of Leading Drugs, 2009 25
• Table 11: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2001-2009 28
• Table 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($m), 2009-2016 28
• Table 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2009 29
• Table 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2009-2016 29
• Table 15: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2009 30
• Table 16: T Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2009-2016 30
• Table 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 32
• Table 18: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2009-2016 32
• Table 19: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2001-2009 38
• Table 20: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Sales Value ($bn), 2009-2016 38
• Table 21: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2001-2009 39
• Table 22: Pain Management Therapeutics Market, Global, Neuropathic Pain Market Patient Volume (Millions), 2009-2016 39
• Table 23: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2001-2009 40
• Table 24: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Treatment ($), 2009-2016 40
• Table 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2001-2009 41
• Table 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Usage Patterns, 2009-2016 42
• Table 27: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn), 2001-2009 48
• Table 28: Pain Management Therapeutics Market, Global, Migraine Diseases Population ($ bn), 2009-2016 48
• Table 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2009 49
• Table 30: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2009-2016 49
• Table 31: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2009 50
• Table 32: Pain Management Therapeutics Market, Global, Annual Cost of Migraine Treatment ($), 2001-2009 50
• Table 33: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2001-2009 52
• Table 34: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions), 2009-2016 52
• Table 35: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2001-2009 58
• Table 36: Pain Management Therapeutics Market, Global, Cancer Pain Diseases Population ($ bn), 2009-2016 58
• Table 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2009 59
• Table 38: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2009-2016 59
• Table 39: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2009 60
• Table 40: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2009-2016 60
• Table 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2001-2009 61
• Table 42: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns (millions), 2009-2016 62
• Table 43: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2001-2009 67
• Table 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($bn), 2009-2016 67
• Table 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2001-2009 68
• Table 46: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (million), 2009-2016 68
• Table 47: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2009 69
• Table 48: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2009-2016 69
• Table 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2001-2009 70
• Table 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns (million), 2009-2016 71
• Table 51: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2009 77
• Table 52: Pain Management Therapeutics Market, Global, Sales Value by Geography ($ bn), 2009-2016 77
• Table 53: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2009 78
• Table 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2009-2016 78
• Table 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2009 79
• Table 56: Pain Management Therapeutics Market, US, Patient Volume (million), 2009-2016 79
• Table 57: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2009 80
• Table 58: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2009-2016 80
• Table 59: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2001-2009 81
• Table 60: Pain Management Therapeutics Market, the US, Treatment Usage Patterns (million), 2009-2016 82
• Table 61: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2009 86
• Table 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2009-2016 86
• Table 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2009 87
• Table 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2009-2016 87
• Table 65: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2009 88
• Table 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2009-2016 88
• Table 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2009 89
• Table 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2009-2016 90
• Table 69: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2009 94
• Table 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2009-2016 94
• Table 71: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2001-2009 95
• Table 72: Pain Management Therapeutics Market, Japan, Patient Volume (million), 2009-2016 95
• Table 73: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2009 96
• Table 74: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2009-2016 96
• Table 75: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2009 98
• Table 76: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions) , 2009-2016 98
• Table 77: Pain Management Therapeutics Market, Global, Competitive Landscape, 2009 114
• Table 78: Pain Management Therapeutics Market, Merck, Pipeline Products, December 2009 116
• Table 79: Pain Management Therapeutics Market, Eli Lilly, Pipeline Products, 2010 117
• Table 80: Pain Management Therapeutics Market, J&J, Pipeline Products, 2010 120
• Table 81: Pain Management Therapeutics Market, Endo Pharmaceuticals, Pipeline Products, 2010 121
• Table 82: Pain Management Therapeutics Market, Novartis, Pipeline Products, 2010 123
• Table 83: Pain Management Therapeutics Market, Merck & Co, Inc., Pipeline Products, 2010 124
• Table 84: Cephalon Inc. – Pain Pipeline Products, 2009 125
• Table 85: Pain Management Therapeutics Market, Global, Major M&A Deals, 2009-2010 127
• Table 86: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008-2009 132
• Table 87: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I, 2008-2009 133
• Table 88: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase II, 2008-2009 133
• Table 89: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs in Phase III, 2008-2009 134
• Table 90: Pain Management Therapeutics Market, Global, Licensing Agreements for Drugs Which are Approved or Awaiting Approval, 2008-2009 135

1.2 List of Figures

• Figure 1: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2000-2016 15
• Figure 2: Pain Management Therapeutics Market, Global, Volume (Millions), 2001-2016 16
• Figure 3: Pain Management Therapeutics Market, Global, Annual Cost of Therapy ($), 2000-2015 17
• Figure 4: Pain Management Therapeutics Market, Global, Treatment Usage Patterns, 2000-2015 18
• Figure 5: Pain Management Therapeutics Market, Global, Diseased Population (Millions), 2001-2016 19
• Figure 6: Pain Management Therapeutics Market, Global, Treatment Seeking Population (Millions), 2001-2016 20
• Figure 7: Pain Management Therapeutics Market, Global, Diagnosed Population (Millions), 2001-2016 21
• Figure 8: Pain Management Therapeutics Market, Global, Prescription Population (Millions), 2001-2016 22
• Figure 9: Pain Management Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($m), 2009-2016 23
• Figure 10: Pain Management Therapeutics Market, Global, Growth Parameters, 2009 25
• Figure 11: Pain Management Therapeutics Market, Global, Sales Value by Indication (%) 2009 and 2016 26
• Figure 12: Pain Management Therapeutics Market, Global, Fibromyalgia Sales Value ($ bn), 2001-2016 27
• Figure 13: Pain Management Therapeutics Market, Global, Fibromyalgia, Patient Volume (Millions), 2001-2016 28
• Figure 14: Pain Management Therapeutics Market, Global, Fibromyalgia, Annual Cost of Therapy ($), 2001-2016 29
• Figure 15: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Usage Patterns, 2001-2009 30
• Figure 16: Pain Management Therapeutics Market, Global, Fibromyalgia Diseased Population (Millions), 2001-2016 32
• Figure 17: Pain Management Therapeutics Market, Global, Fibromyalgia Treatment Seeking Population (Millions), 2001-2016 33
• Figure 18: Pain Management Therapeutics Market, Global, Fibromyalgia Diagnosed Population (Millions), 2001-2016 34
• Figure 19: Pain Management Therapeutics Market, Global, Fibromyalgia Prescription Population (Millions), 2001-2016 35
• Figure 20: Pain Management Therapeutics Market, Global, Sales Value ($ bn), 2001-2016 37
• Figure 21: Pain Management Therapeutics Market, Global, Neuropathic Pain, Patient Volume (Millions), 2001-2016 38
• Figure 22: Pain Management Therapeutics Market, Global, Neuropathic Pain, Annual Cost of Therapy ($), 2001-2016 39
• Figure 23: Pain Management Therapeutics Market, Global, Neuropathic Treatment Usage Patterns, 2001-2016 40
• Figure 24: Pain Management Therapeutics Market, Global, Neuropathic Pain Diseased Population (Millions), 2001-2016 42
• Figure 25: Pain Management Therapeutics Market, Global, Neuropathic Pain Treatment Seeking Population (Millions), 2001-2016 43
• Figure 26: Pain Management Therapeutics Market, Global, Neuropathic Pain Diagnosed Population (Millions), 2001-2016 44
• Figure 27: Pain Management Therapeutics Market, Global, Neuropathic Pain Prescription Population (Millions), 2001-2016 45
• Figure 28: Pain Management Therapeutics Market, Global, Migraine Sales Value ($ bn), 2001-2016 47
• Figure 29: Pain Management Therapeutics Market, Global, Migraine Market Patient Volume (Millions), 2001-2016 48
• Figure 30: Pain Management Therapeutics Market, Global, Migraine, Annual Cost of Therapy ($), 2001-2016 49
• Figure 31: Pain Management Therapeutics Market, Global, Migraine Treatment Usage Patterns (Millions) , 2001-2016 50
• Figure 32: Pain Management Therapeutics Market, Global, Migraine Diseased Population (Millions), 2001-2016 52
• Figure 33: Pain Management Therapeutics Market, Global, Migraine Treatment Seeking Population (Millions), 2001-2016 53
• Figure 34: Pain Management Therapeutics Market, Global, Migraine Diagnosed Population (Millions), 2001-2016 54
• Figure 35: Pain Management Therapeutics Market, Global, Migraine Prescription Population (Millions), 2001-2016 55
• Figure 36: Pain Management Therapeutics Market, Global, Cancer Pain Sales Value ($ bn), 2001-2016 57
• Figure 37: Pain Management Therapeutics Market, Global, Cancer Pain Market Patient Volume (Millions), 2001-2016 58
• Figure 38: Pain Management Therapeutics Market, Global, Cancer Pain, Annual Cost of Therapy ($), 2001-2016 59
• Figure 39: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Usage Patterns, 2001-2016 60
• Figure 40: Pain Management Therapeutics Market, Global, Cancer Pain Diseased Population, 2001-2016 61
• Figure 41: Pain Management Therapeutics Market, Global, Cancer Pain Treatment Seeking Population, 2001-2016 62
• Figure 42: Pain Management Therapeutics Market, Global, Cancer Pain Diagnosed Population, 2001-2016 63
• Figure 43: Pain Management Therapeutics Market, Global, Cancer Pain Prescription Population, 2001-2016 64
• Figure 44: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Sales Value ($ bn), 2001-2016 66
• Figure 45: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Market Patient Volume (Millions), 2001-2016 67
• Figure 46: Pain Management Therapeutics Market, Global, of Osteoarthritis Pain, Annual Cost of Therapy ($), 2001-2016 68
• Figure 47: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Usage Patterns, 2001-2016 69
• Figure 48: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diseased Population, 2001-2016 70
• Figure 49: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Treatment Seeking Population, 2001-2016 71
• Figure 50: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Diagnosed Population, 2001-2016 72
• Figure 51: Pain Management Therapeutics Market, Global, Osteoarthritis Pain Prescription Population, 2001-2016 73
• Figure 52: Pain Management Therapeutics Market, Global, Market Share by Geography, 2009 and 2016 75
• Figure 53: Pain Management Therapeutics Market, Global, Sales Value by Geography ($bn), 2001-2016 76
• Figure 54: Pain Management Therapeutics Market, US, Sales Value ($ bn), 2001-2016 77
• Figure 55: Pain Management Therapeutics Market, US, Patient Volume (million), 2001-2016 78
• Figure 56: Pain Management Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2016 79
• Figure 57: Pain Management Therapeutics Market, US, Treatment Usage Patterns, 2001-2016 80
• Figure 58: Pain Management Therapeutics Market, US, Diseased Population (Millions), 2001-2016 81
• Figure 59: Pain Management Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2016 82
• Figure 60: Pain Management Therapeutics Market, US, Diagnosed Population (Millions), 2001-2016 83
• Figure 61: Pain Management Therapeutics Market, US, Prescription Population (Millions), 2001-2016 84
• Figure 62: Pain Management Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2016 85
• Figure 63: Pain Management Therapeutics Market, Top Five Countries in Europe, Patient Volume (million), 2001-2016 86
• Figure 64: Pain Management Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2016 87
• Figure 65,: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns (Millions), 2001-2016 88
• Figure 66: Pain Management Therapeutics Market, Top Five Countries in Europe, Diseased Population (Millions), 2001-2016 89
• Figure 67: Pain Management Therapeutics Market, Top Five Countries in Europe, Treatment Seeking Population (Millions), 2001-2016 90
• Figure 68: Pain Management Therapeutics Market, Top Five Countries in Europe, Diagnosed Population (Millions), 2001-2016 91
• Figure 69: Pain Management Therapeutics Market, Top Five Countries in Europe, Prescription Population (Millions), 2001-2016 92
• Figure 70: Pain Management Therapeutics Market, Japan, Sales Value ($ bn), 2001-2016 93
• Figure 71: Pain Management Therapeutics Market, Japan, Patient Volume (million) , 2001-2016 94
• Figure 72: Pain Management Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2016 95
• Figure 73: Pain Management Therapeutics Market, Japan, Treatment Usage Patterns (Millions), 2001-2016 96
• Figure 74: Pain Management Therapeutics Market, Japan, Diseased Population (Millions), 2001-2016 98
• Figure 75: Pain Management Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2016 99
• Figure 76: Pain Management Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2016 100
• Figure 77: Pain Management Therapeutics Market, Japan, Prescription Population (Millions), 2001-2016 101
• Figure 78: Pain Management Therapeutics Market, Global, R&D Pipeline by Indication, December 2009 102
• Figure 79: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase, December 2009 102
• Figure 80: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Fibromyalgia, March 2010 103
• Figure 81: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Neuropathic Pain, March 2010 104
• Figure 82: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Migraine, March 2010 105
• Figure 83: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Cancer Pain, March 2010 106
• Figure 84: Pain Management Therapeutics Market, Global, R&D Pipeline by Phase in Osteoarthritis, March 2010 106
• Figure 85: Pain Management Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 112
• Figure 86: Pain Management Therapeutics Market, Global, Pfizer, Share of Key Pain Drugs Revenue, 2009 114
• Figure 87: Pain Management Therapeutics Market, Global, Eli Lilly and Company, Share of Key Pain Drugs Revenue, 2009 116
• Figure 88: Pain Management Therapeutics Market, Global, Johnson & Johnson, Share of Key Pain Drugs Revenue, 2009 118
• Figure 89: Pain Management Therapeutics Market, Global, Endo Pharmaceuticals, Share of Key Pain Drugs Revenue, 2009 119
• Figure 90: Pain Management Therapeutics Market, Global, Novartis, Share of Key Pain Drugs Revenue, 2009 121
• Figure 91: Pain Management Therapeutics Market, Global, Merck & Co, Inc., Share of Key Pain Drugs Revenue, 2009 123
• Figure 92: Pain Management Therapeutics Market, Global,Cephalon, Share of Key Pain Drugs Revenue, 2009 124
• Figure 93: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Indication, 2008-2010 128
• Figure 94: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Phase, 2008-2010 129
• Figure 95: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Geography, 2008-2010 130
• Figure 96: Pain Management Therapeutics Market, Global, Major Licensing Agreements By Value, 2008-2010, n=8 131
• Figure 97: Research Methodology, 2010 137
• Figure 98: Research Market Forecasting Model, 2010 140

Other users found this report page using the following search terms: neuropathic pain osteoarthritis cancer pain migraine fibromyalgia pain market management size osteoarthritis tanezumab cancer leading osteoarthritispatientsmedicationannualcostinuseurope diabetic

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.

Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.